SK AKIB JAVED REPORT

Patient Name : Mr.
SK AKIB JAVED Collected : 07/Jan/2025 10:35AM

Age/Gender : 27 Y 0 M 0 D /M Received : 07/Jan/2025 03:38PM
UHID/MR No : DCII.0000005355 Reported : 07/Jan/2025 07:13PM
Visit ID : DCIIOPV5368 Status : Final Report
Ref Doctor : S P SANTRA Client Name : DDC SUGAR CLINIC SHAPOORJI
IP/OP NO : Center location : Kolkata,Kolkata
DEPARTMENT OF HAEMATOLOGY
XPERT HEALTH FEVER ASSESSMENT ADVANCE
Test Name Result Unit Bio. Ref. Interval Method

COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD EDTA
HAEMOGLOBIN 13 g/dL 13-17 Spectrophotometer
PCV 39.00 % 40-50 Electronic pulse &
Calculation
RBC COUNT 4.78 Million/cu.mm 4.5-5.5 Electrical Impedence
MCV 81.7 fL 83-101 Calculated
MCH 27.3 pg 27-32 Calculated
MCHC 33.4 g/dL 31.5-34.5 Calculated
R.D.W 14.8 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 6,740 cells/cu.mm 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 54 % 40-80 Electrical Impedance
LYMPHOCYTES 32 % 20-40 Electrical Impedance
EOSINOPHILS 4 % 1-6 Electrical Impedance
MONOCYTES 10 % 2-10 Electrical Impedance
BASOPHILS 0 % <1-2 Electrical Impedance
CORRECTED TLC 6,740 Cells/cu.mm Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 3639.6 Cells/cu.mm 2000-7000 Calculated
LYMPHOCYTES 2156.8 Cells/cu.mm 1000-3000 Calculated
EOSINOPHILS 269.6 Cells/cu.mm 20-500 Calculated
MONOCYTES 674 Cells/cu.mm 200-1000 Calculated
Neutrophil lymphocyte ratio (NLR) 1.69 0.78- 3.53 Calculated
PLATELET COUNT 222000 cells/cu.mm 150000-410000 Electrical impedence
Page 1 of 7
SIN No:HA08282686
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Mr.SK AKIB JAVED Collected : 07/Jan/2025 10:35AM
DEPARTMENT OF HAEMATOLOGY

ERYTHROCYTE SEDIMENTATION 14 mm at the 0-15 Modified Westergren
RATE (ESR) , WHOLE BLOOD EDTA end of 1 hour

MALARIA VIVAX ANTIGEN , WHOLE NEGATIVE NEGATIVE Immunochromotography.
BLOOD EDTA
MALARIA FALCIPARUM ANTIGEN , NEGATIVE NEGATIVE Immunochromotography
WHOLE BLOOD EDTA
Comment:
The test detects the presence of Plasmodium lactate dehydrogenase, an enzyme produced by all forms of the parasite.
This is only a screening test. The results are to be interpreted within the epidemiological, clinical and therapeutic context. In most of
the cases, after successful anti-malarial therapy the result will turn negative. However, sometimes the clearance of parasite may
take longer and test may remain positive. In such cases the test should be repeated after 5-10 days of start of treatment. The
possibility of resistant strain of malaria should always be considered if the reaction of the test remains positive with after 5-10 days
post treatment.
Page 2 of 7
SIN No:HA08282686
DEPARTMENT OF BIOCHEMISTRY

C-REACTIVE PROTEIN CRP 10.4 mg/L <5 Latex Particle
(QUANTITATIVE) , SERUM Immunoturbidimetric
Comment:
C-reactive protein (CRP) is one of the most sensitive acute-phase reactants for inflammation. Measuring changes in the
concentration of CRP provides useful diagnostic information about the level of acuity and severity of a disease. Unlike ESR, CRP
levels are not influenced by hematologic conditions such as anemia, polycythemia etc.
Increased levels are consistent with an acute inflammatory process. After onset of an acute phase response, the serum CRP
concentration rises rapidly (within 6-12 hours and peaks at 24-48 hours) and extensively.Concentrations above 100 mg/L are
associated with severe stimuli such as major trauma and severe infection (sepsis).
Page 3 of 7
SIN No:BI23569714
DEPARTMENT OF SEROLOGY

WIDAL TEST (SLIDE METHOD)
SALMONELLA TYPHI `O` , SERUM <1:80 SLIDE
AGGLUTINATION
SALMONELLA TYPHI `H` , SERUM <1:80 SLIDE
AGGLUTINATION
S.PARATYPHI A `H` , SERUM <1:80 SLIDE
AGGLUTINATION
S.PARATYPHI B `H` , SERUM <1:80 SLIDE
AGGLUTINATION
Comment:
Note:
1. Titres 1:80 and above of “O” antigen & 1:160 and above of “H” antigen are significant
2. Rising titers are significant
Comments: This test measures somatic O and flagellar H antibodies against Typhoid and Paratyphoid bacilli. The agglutinins
usually appear at the end of the first week of infection and increase steadily till third / fourth week after which they start declining. A
positive Widal test may occur because of typhoid vaccination or previous typhoid infection and in certain autoimmune diseases.
Non-specific febrile disease may cause this titer to increase. The test may be falsely negative in cases of Enteric fever treated with
antibiotics in the early stages. The recommended test especially in the first week after infection is Blood Culture.
Page 4 of 7
SIN No:SE02519646

DENGUE NS1 ANTIGEN , SERUM 0.01 INDEX <1 ELISA with Fluorescent
Detection
Comment:
RESULT (Dengue NS1 Antigen) INTERPRETATION
<1 INDEX NEGATIVE
≥1 INDEX POSITIVE
This is only a screening test and will only indicate the presence or absence of Dengue NS1 antigen in the specimen. All reactive
samples should be confirmed by confirmatory test.
Results should be interpreted after taking into consideration the patient’s clinical history and symptomatology. False positive results
can be obtained due to cross reaction with Murray Valley and encephalitis, Japanese encephalitis, yellow fever and West Nile
viruses
Page 5 of 7
SIN No:SE02519646

TYPHIDOT - IGM , SERUM NEGATIVE NEGATIVE ICT
Comment:
• Typhi IgM & IgG Card is a rapid solid phase immuno-chromatographic test for the qualitative differential and simultaneous
detection of salmonella typhi (S. typhi) IgM and IgG antibodies in human serum / plasma.
• In early infections and some secondary infections, detectable levels of IgM antibodies may be low. Some patients may not
produce detectable levels of antibody within the first seven to ten days after infection. Where symptoms persist, patients should be
re- tested 3-5 days after the first testing date.
• High titre of Rheumatoid arthritis antibodies, SLE antibodies may show cross-reactivity.
• As with all diagnostic tests, all results must be correlated with other clinical findings. If the test result is negative and clinical
symptoms persist, additional follow-up testing using other clinical methods is recommended. A negative result at any time does not
preclude the possibility of an early infection of typhoid bacteria.
• This is only a screening test. Therefore, more specific alternative diagnosis method such as tube test and culture must be used in
order to obtain a confirmation of typhoid infection.
Page 6 of 7
SIN No:SE02519646

DENGUE IGG & IGM , SERUM
DENGUE IgG ANTIBODIES 46.73 INDEX <1 ELISA with Fluorescent
Detection
DENGUE IgM ANTIBODIES 0.15 INDEX <1 ELISA with Fluorescent
Detection
Comment:
RESULT (Dengue IgG & IgM Antibodies) INTERPRETATION
<1 INDEX NEGATIVE
≥1 INDEX POSITIVE
This is only a screening test and will only indicate the presence or absence of Dengue NS1 antigen and Dengue IgG&IgM
antibodies in the specimen. All reactive samples should be confirmed by confirmatory test.
Results should be interpreted after taking into consideration the patient’s clinical history and symptomatology. False positive NS1
antigen results can be obtained due to cross reaction with Murray Valley and encephalitis, Japanese encephalitis, yellow fever and
West Nile viruses.False positive antibody results can be obtained due to cross reaction with Epstein-Barr virus, RA, Leptospira,
Malaria, Hepatitis-A, Influenza A& B, S. typhi, Japanese encephalites, West Nile virus disease. Immunosuppressive treatments
may induce negative IgG or IgM results in Dengue patients.
*** End Of Report ***

Result/s to Follow:
COMPLETE URINE EXAMINATION (CUE)
Page 7 of 7
SIN No:SE02519646
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.
SIN No:SE02519646

SK AKIB JAVED REPORT

Uploaded by

Copyright:

Available Formats

SK AKIB JAVED REPORT

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

SK AKIB JAVED REPORT

Uploaded by

Copyright:

Available Formats

Patient Name : Mr.

SK AKIB JAVED Collected : 07/Jan/2025 10:35AM

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

Test Name Result Unit Bio. Ref. Interval Method

* End Of Report *

TERMS AND CONDITIONS GOVERNING THIS REPORT

You might also like